LAUREN BOWLING: Open Payments
NPI 1629788013 · RUSSELLVILLE, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$452 in 26 payments from 7 companies in 2025. Trend: 2023 $130 · 2024 $176 · 2025 $452
Food & beverage: $452
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 11 | $158 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 7 | $132 |
| Axsome Therapeutics, Inc. | 3 | $69 |
| Janssen Pharmaceuticals, Inc | 2 | $40 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $20 |
| Otsuka America Pharmaceutical, Inc. | 1 | $17 |
| Lundbeck LLC | 1 | $16 |
Products named: VRAYLAR, CAPLYTA, Auvelity, SPRAVATO, REXULTI, TRINTELLIX.
Industry payments across AR — which companies pay providers there.
